FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jerry Spivak

Research Profile

Chemicals & Drugs

Disorders

Physiology

Living Beings

Mouse

Anatomy

Procedures

Colony Forming Units Assays

Phenomena

Hematocrit

Co-author Network

Publications

TOP 3
Huichun Zhan; Antai Wang; Wayne Yu; Christopher Cardozo; Chi Dang; Alison R Moliterno; Jerry L Spivak
MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients.
Jerry L Spivak
Polycythemia vera, the hematocrit, and blood-volume physiology.
Richard T Silver; Steven Fruchtman; Jerry L Spivak; Michael H Bourla; Eric J Feldman; Katherine Vandris; August J Salvado
Treatment of polycythemia vera with imatinib mesylate.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jerry Spivak (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Huichun Zhan; Antai Wang; Wayne Yu; Christopher Cardozo; Chi Dang; Alison R Moliterno; Jerry L Spivak
MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients.
Blood cells, molecules & diseases 2013;50(3):190-5.
2013: Jerry L Spivak
Polycythemia vera, the hematocrit, and blood-volume physiology.
The New England journal of medicine 2013;368(1):76-8.
2012: Richard T Silver; Steven Fruchtman; Jerry L Spivak; Michael H Bourla; Eric J Feldman; Katherine Vandris; August J Salvado
Treatment of polycythemia vera with imatinib mesylate.
Leukemia research 2012;36(2):156-62.
2011: BRADY STEIN; Amit Verma; Donna M Williams; Christine O'Keefe; Ophelia Rogers; Jerry L Spivak; Roxann G Ingersoll; Jarek P Maciejewski; A MICHAEL MCDEVITT; Alison R Moliterno
Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.
Haematologica 2011;96(10):1462-9.
2011: Jerry L Spivak; Richard T Silver
The treatment of essential thromobocytosis revisited.
Blood 2011;118(4):1179-80; author reply 1180-1.
2011: Jerry L Spivak
Iron and the anemia of chronic disease: vindication for the non-essential role of iron supplementation.
Oncology (Williston Park, N.Y.) 2011;25(5):421-3.
2011: Jerry L Spivak; Hans Hasselbalch
Hydroxycarbamide: a user's guide for chronic myeloproliferative disorders.
Expert review of anticancer therapy 2011;11(3):403-14.
2011: BRADY STEIN; Alfred Rademaker; Jerry L Spivak; Alison R Moliterno
Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms.
Thrombosis 2011;2011():874146.
2011: BRADY STEIN; Donna M Williams; Ophelia Rogers; Mary Ann Isaacs; Jerry L Spivak; Alison R Moliterno
Disease burden at the progenitor level is a feature of primary myelofibrosis: a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients.
Experimental hematology 2011;39(1):95-101.
2010: J Douglas Rizzo; Melissa Brouwers; Patricia Hurley; Jerome Seidenfeld; Murat O Arcasoy; Jerry L Spivak; Charles L Bennett; Julia Bohlius; Darren Evanchuk; Matthew J Goode; Ann Jakubowski; David H Regan; Mark R Somerfield
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):4996-5010.
2010: J Douglas Rizzo; Melissa Brouwers; Patricia Hurley; Jerome Seidenfeld; Murat O Arcasoy; Jerry L Spivak; Charles L Bennett; Julia Bohlius; Darren Evanchuk; Matthew J Goode; Ann Jakubowski; David H Regan; Mark R Somerfield
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
Blood 2010;116(20):4045-59.
2010: BRADY STEIN; Donna M Williams; Nae-Yuh Wang; Ophelia Rogers; Mary Ann Isaacs; Naveen Pemmaraju; Jerry L Spivak; Alison R Moliterno
Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders.
Haematologica 2010;95(7):1090-7.
2010: Jerry L Spivak
An inconvenient truth.
Blood 2010;115(14):2727-8.
2010: Jerry L Spivak
Narrative review: Thrombocytosis, polycythemia vera, and JAK2 mutations: The phenotypic mimicry of chronic myeloproliferation.
Annals of internal medicine 2010;152(5):300-6.
2009: Zhaohui Ye; Huichun Zhan; Prashant Mali; Sarah Dowey; Donna M Williams; YOON YOUNG JANG; Chi Dang; Jerry L Spivak; Alison R Moliterno; Linzhao Cheng
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.
Blood 2009;114(27):5473-80.
2009: Huichun Zhan; Jerry L Spivak
The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
Clinical advances in hematology & oncology : H&O 2009;7(5):334-42.
2009: Jerry L Spivak; Pere Gascón; Heinz Ludwig
Anemia management in oncology and hematology.
The oncologist 2009;14 Suppl 1():43-56.
2009: Matti Aapro; Jerry L Spivak
Update on erythropoiesis-stimulating agents and clinical trials in oncology.
The oncologist 2009;14 Suppl 1():6-15.
2009: Ashkan Emadi; Jerry L Spivak
Anagrelide: 20 years later.
Expert review of anticancer therapy 2009;9(1):37-50.
2008: Alison R Moliterno; Donna M Williams; Ophelia Rogers; Mary Ann Isaacs; Jerry L Spivak
Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens.
Experimental hematology 2008;36(11):1480-6.
2008: Jerry L Spivak
MPDs: it's all in the family.
Blood 2008;112(6):2173-4.
2008: Jerry L Spivak; Richard T Silver
The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal.
Blood 2008;112(2):231-9.
2007: Donna M Williams; Ann H Kim; Ophelia Rogers; Jerry L Spivak; Alison R Moliterno
Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.
Experimental hematology 2007;35(11):1641-6.
2007: Jerry L Spivak
Phenotype and genotype in the myeloproliferative disorders.
European journal of haematology. Supplementum 2007;(68):9-12.
2007: N Pemmaraju; Alison R Moliterno; Donna M Williams; Ophelia Rogers; Jerry L Spivak
The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis.
Leukemia 2007;21(10):2210-2.
2007: Richard T Silver; john bennett; J M Goldman; Jerry L Spivak; Ayalew Tefferi
The third International Congress on Myeloproliferative and Myelodysplastic Syndromes.
Leukemia research 2007;31(1):11-7.
2006: Alison R Moliterno; Donna M Williams; Ophelia Rogers; Jerry L Spivak
Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression.
Blood 2006;108(12):3913-5.
2006: Jerry L Spivak; Alison R Moliterno; Richard T Silver
Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2.
The New England journal of medicine 2006;355(7):737; author reply 738.
2005: Lawrence T Goodnough; Aryeh Shander; Jerry L Spivak; Jonathan H Waters; Arnold J Friedman; Jeffrey L Carson; E Michael Keating; Thomas Maddox; Richard Spence
Detection, evaluation, and management of anemia in the elective surgical patient.
Anesthesia and analgesia 2005;101(6):1858-61.
2005: Jerry L Spivak
Prediction of chemotherapy-induced anaemia: is knowledge really power?
The lancet oncology 2005;6(11):822-4.
2005: Jerry L Spivak
Anemia in the elderly: time for new blood in old vessels?
Archives of internal medicine 2005;165(19):2187-9.
2005: Ayalew Tefferi; Jerry L Spivak
Polycythemia vera: scientific advances and current practice.
Seminars in hematology 2005;42(4):206-20.
2005: Jerry L Spivak
Haematological manifestations of systemic disease.
Clinical medicine (London, England) 2005;5(4):322-5.
2005: Jerry L Spivak
The anaemia of cancer: death by a thousand cuts.
Nature reviews. Cancer 2005;5(7):543-55.
2005: Philipp L Goerttler; Edith März; Peter L Johansson; Björn Andreasson; Jack Kutti; Alison R Moliterno; Roberto Marchioli; Jerry L Spivak; Heike L Pahl
Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels.
Haematologica 2005;90(6):851-3.
2005: Damiano Rondelli; Giovanni Barosi; Andrea Bacigalupo; Josef T Prchal; Uday Popat; Emilio Paolo Alessandrino; Jerry L Spivak; B Douglas Smith; Hans G Klingemann; Steven Fruchtman; Ronald Hoffman
Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia.
Blood 2005;105(10):4115-9.
2004: Richard T Silver; john bennett; Michael W N Deininger; Eric Feldman; Shahin Rafii; R L Silverstein; Lawrence Solberg; Jerry L Spivak
The second international congress on myeloproliferative and myelodysplastic syndromes.
Leukemia research 2004;28(9):979-85.
2004: Alison R Moliterno; Donna M Williams; LAURA GUTIERREZ-ALAMILLO; Roberto Salvatori; Roxann G Ingersoll; Jerry L Spivak
Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(31):11444-7.
2004: Jerry L Spivak; Richard T Silver
Imatinib mesylate in polycythemia vera.
Blood 2004;103(8):3241; author reply 3241-2.
2004: Donald C Malins; Katie M Anderson; Nayak L Polissar; Gary K Ostrander; Edward T Knobbe; Virginia M Green; Naomi K Gilman; Jerry L Spivak
Models of granulocyte DNA structure are highly predictive of myelodysplastic syndrome.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(14):5008-11.
2004: Jerry L Spivak
The chronic myeloproliferative disorders: clonality and clinical heterogeneity.
Seminars in hematology 2004;41(2 Suppl 3):1-5.
2004: Jerry L Spivak
Daily aspirin--only half the answer.
The New England journal of medicine 2004;350(2):99-101.
2003: Douglas T Dieterich; Jerry L Spivak
Hematologic disorders associated with hepatitis C virus infection and their management.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(4):533-41.
2003: Jerry L Spivak
Maxwell Wintrobe, in his own words.
British journal of haematology 2003;121(2):224-32.
2003: Jerry L Spivak; Giovanni Barosi; Gianni Tognoni; Tiziano Barbui; Guido Finazzi; Roberto Marchioli; Monia Marchetti
Chronic myeloproliferative disorders.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2003;():200-24.
2003: Jerry L Spivak
Diagnosis of the myeloproliferative disorders: resolving phenotypic mimicry.
Seminars in hematology 2003;40(1 Suppl 1):1-5.
2003: Jerry L Spivak
Polycythemia vera and the emperor's new clothes.
Haematologica 2003;88(1):1-4.
2002: Jerry L Spivak
Polycythemia vera: myths, mechanisms, and management.
Blood 2002;100(13):4272-90.
2002: Jerry L Spivak
Diagnostic evaluation of the chronic myeloproliferative disorders.
The Israel Medical Association journal : IMAJ 2002;4(11):1028-31.
2002: Jerry L Spivak
Iron and the anemia of chronic disease.
Oncology (Williston Park, N.Y.) 2002;16(9 Suppl 10):25-33.
2002: Michael B Streiff; Bradley R Smith; Jerry L Spivak
The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns.
Blood 2002;99(4):1144-9.
2002: Jerry L Spivak
The optimal management of polycythaemia vera.
British journal of haematology 2002;116(2):243-54.
2001: Michael B Streiff; L Dundes; Jerry L Spivak
A mail survey of United States hematologists and oncologists: a comparison of business reply versus stamped return envelopes.
Journal of clinical epidemiology 2001;54(4):430-2.
2001: Jerry L Spivak
Erythropoietin use and abuse: When physiology and pharmacology collide.
Advances in experimental medicine and biology 2001;502():207-24.
2000: Jerry L Spivak; M Cazzola
Current thinking and treatment practices in anaemia--an interactive poll.
Medical oncology (Northwood, London, England) 2000;17 Suppl 1():S32-7.
2000: Jerry L Spivak
The blood in systemic disorders.
Lancet 2000;355(9216):1707-12.
1999: Alison R Moliterno; Jerry L Spivak
Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera.
Blood 1999;94(8):2555-61.
1998: Robert A Brodsky; Michelle Petri; B Douglas Smith; EJ Seifter; Jerry L Spivak; Michael J Styler; Chi Dang; Isadore Brodsky; Richard J Jones
Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.
Annals of internal medicine 1998;129(12):1031-5.
1998: Jerry L Spivak
The biology and clinical applications of recombinant erythropoietin.
Seminars in oncology 1998;25(3 Suppl 7):7-11.
1998: Alison R Moliterno; William David Hankins; Jerry L Spivak
Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
The New England journal of medicine 1998;338(9):572-80.
1998: Alison R Moliterno; K E Siebel; A Y Sun; William David Hankins; Jerry L Spivak
A novel thrombopoietin signaling defect in polycythemia vera platelets.
Stem cells (Dayton, Ohio) 1998;16 Suppl 2():185-92.
1996: Alison R Moliterno; Jerry L Spivak
Anemia of cancer.
Hematology/oncology clinics of North America 1996;10(2):345-63.
1996: Jerry L Spivak; D K Ferris; J Fisher; Stephen J Noga; M Isaacs; E Connor; William David Hankins
Cell cycle-specific behavior of erythropoietin.
Experimental hematology 1996;24(2):141-50.
1996: Jerry L Spivak; L S Avedissian; J H Pierce; D Williams; William David Hankins; R A Jensen
Isolation of the full-length murine erythropoietin receptor using a baculovirus expression system.
Blood 1996;87(3):926-37.
1995: L S Avedissian; I Poola; Jerry L Spivak
Ligand binding kinetics of a soluble full-length murine erythropoietin receptor.
Biochemical and biophysical research communications 1995;216(1):62-8.
1995: R Hamanaka; M R Smith; Patrick M O'Connor; S Maloid; K Mihalic; Jerry L Spivak; Dan Longo; Douglass K Ferris
Polo-like kinase is a cell cycle-regulated kinase activated during mitosis.
The Journal of biological chemistry 1995;270(36):21086-91.
1995: D H Henry; Jerry L Spivak
Clinical use of erythropoietin.
Current opinion in hematology 1995;2(2):118-24.
1995: Jerry L Spivak
Serum immunoreactive erythropoietin in health and disease.
Journal of perinatal medicine 1995;23(1-2):13-7.
1994: Jerry L Spivak; E Connor; M Isaacs
Erythropoietin stimulates serine kinase activity in erythropoietin-dependent cells.
Experimental hematology 1994;22(12):1141-6.
1994: Jerry L Spivak
Recombinant human erythropoietin and the anemia of cancer.
Blood 1994;84(4):997-1004.
1994: D M Williams; Teresa Zimmers; J H Pierce; P N Pharr; A N Schechter; Stephen T Sawyer; S K Ruscetti; Jerry L Spivak; William David Hankins
The expression and role of human erythropoietin receptor in erythroid and nonerythroid cells.
Annals of the New York Academy of Sciences 1994;718():232-43; discussion 243-4.
1994: Jerry L Spivak
Cancer-related anemia: its causes and characteristics.
Seminars in oncology 1994;21(2 Suppl 3):3-8.
1994: J Clemens; Jerry L Spivak
Serum immunoreactive erythropoietin during the perioperative period.
Surgery 1994;115(4):510-5.
1994: Jerry L Spivak
Sports hematology: serious concept or trivial pursuit. Introduction.
Seminars in hematology 1994;31(2):99-101.
1994: Jerry L Spivak; D Henry; J Glaspy
Retroviral diseases in hematology.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 1994;Suppl():40-6.
1994: J W Adamson; Jerry L Spivak
Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment.
Surgery 1994;115(1):7-15.
1994: Jerry L Spivak
Recombinant human erythropoietin and its role in transfusion medicine.
Transfusion 1994;34(1):1-4.
1993: Jerry L Spivak
The clinical physiology of erythropoietin.
Seminars in hematology 1993;30(4 Suppl 6):2-11.
1993: Jerry L Spivak
Recombinant erythropoietin.
Annual review of medicine 1993;44():243-53.
1992: Carole B Miller; Richard J Jones; Marianna Zahurak; Steven Piantadosi; W H Burns; G W Santos; Jerry L Spivak
Impaired erythropoietin response to anemia after bone marrow transplantation.
Blood 1992;80(10):2677-82.
1992: Jerry L Spivak
The application of recombinant erythropoietin in anemic patients with cancer.
Seminars in oncology 1992;19(3 Suppl 8):25-8.
1992: Eric K Rowinsky; BA Conley; Richard J Jones; Jerry L Spivak; M Auerbach; Ross C Donehower
Hexamethylene bisacetamide in myelodysplastic syndrome: effect of five-day exposure to maximal therapeutic concentrations.
Leukemia 1992;6(6):526-34.
1992: Jerry L Spivak; J Fisher; M A Isaacs; William David Hankins
Protein kinases and phosphatases are involved in erythropoietin-mediated signal transduction.
Experimental hematology 1992;20(4):500-4.
1992: Jerry L Spivak
Calcium and the erythroblast.
Experimental hematology 1992;20(3):283-5.
1992: L S Lehmann; Jerry L Spivak
Rapid and definitive diagnosis of infectious diseases using peripheral blood smears.
Journal of intensive care medicine 1992;7(1):36-47.
1991: M P Carroll; Jerry L Spivak; M McMahon; N Weich; U R Rapp; W S May
Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation.
The Journal of biological chemistry 1991;266(23):14964-9.
1991: Jerry L Spivak; T Pham; M Isaacs; William David Hankins
Erythropoietin is both a mitogen and a survival factor.
Blood 1991;77(6):1228-33.
1991: J P Weber; Patrick C Walsh; C A Peters; Jerry L Spivak
Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men.
American journal of hematology 1991;36(3):190-4.
1991: Jerry L Spivak
Erythropoietin: from bench to bedside.
Transactions of the American Clinical and Climatological Association 1991;102():232-42; discussion 242-4.
1991: J S Powers; S B Krantz; Jerry Collins; K Meurer; A Failinger; T Buchholz; M Blank; Jerry L Spivak; M Hochberg; ALAN BAER
Erythropoietin response to anemia as a function of age.
Journal of the American Geriatrics Society 1991;39(1):30-2.
1990: Eric K Rowinsky; Ross C Donehower; Jerry L Spivak; P J Burke; Constance A Griffin; Richard J Jones
Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors.
Journal of the National Cancer Institute 1990;82(24):1926-31.
1990: David K Klassen; Jerry L Spivak
Hepatitis-related hepatic erythropoietin production.
The American journal of medicine 1990;89(5):684-6.
1990: A J Watson; Luis F Gimenez; S Cotton; M Walser; Jerry L Spivak
Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
The American journal of medicine 1990;89(4):432-5.
1990: Carole B Miller; Richard J Jones; Steven Piantadosi; M D Abeloff; Jerry L Spivak
Decreased erythropoietin response in patients with the anemia of cancer.
The New England journal of medicine 1990;322(24):1689-92.
1990: Jerry L Spivak
Erythropoietin: a new paradigm.
The Journal of laboratory and clinical medicine 1990;115(1):10-1.
1990: Luis F Gimenez; A J Watson; Jerry L Spivak
Serum immunoreactive erythropoietin in patients with end stage renal disease.
Progress in clinical and biological research 1990;352():493-504.
1990: Jerry L Spivak
Application of recombinant human erythropoietin in oncology.
Cancer investigation 1990;8(2):301-2.
1990: Jerry L Spivak
Serum immunoreactive erythropoietin in health and disease.
International journal of cell cloning 1990;8 Suppl 1():211-24; discussion 224-6.
1990: H K Holland; Jerry L Spivak
The haematological manifestations of acquired immune deficiency syndrome.
Baillière's clinical haematology 1990;3(1):103-14.
1989: W G Keyes; Pamela K Donohue; Jerry L Spivak; M D Jones; F A Oski
Assessing the need for transfusion of premature infants and role of hematocrit, clinical signs, and erythropoietin level.
Pediatrics 1989;84(3):412-7.
1989: H K Holland; Jerry L Spivak
Hemochromatosis.
The Medical clinics of North America 1989;73(4):831-45.
1989: Jerry L Spivak; D C Barnes; Edward J Fuchs; Thomas C Quinn
Serum immunoreactive erythropoietin in HIV-infected patients.
JAMA : the journal of the American Medical Association 1989;261(21):3104-7.
1989: Jerry L Spivak
Erythropoietin.
Blood reviews 1989;3(2):130-5.
1989: Jerry L Spivak
Erythropoietin: a brief review.
Nephron 1989;52(4):289-94.
1989: Jerry L Spivak
The in vivo metabolism of recombinant human erythropoietin.
Contributions to nephrology 1989;76():67-75; discussion 75-7.
1989: Jerry L Spivak
Metabolism of recombinant human erythropoietin in the rat.
Advances in experimental medicine and biology 1989;271():29-38.
1989: Jerry L Spivak; B B Hogans; Robert Stuart
Tumor-promoting phorbol esters support the in vitro proliferation of murine pluripotent hematopoietic stem cells.
The Journal of clinical investigation 1989;83(1):100-7.
1989: Jerry L Spivak; B B Hogans
The in vivo metabolism of recombinant human erythropoietin in the rat.
Blood 1989;73(1):90-9.
1988: N Brookins-Reddix; Jerry L Spivak; R M Watson
Violaceous plaques on the lower extremities. Cutaneous macroglobulinosis.
Archives of dermatology 1988;124(12):1853, 1856.
1988: A J Watson; Jerry L Spivak
Recombinant human erythropoietin therapy in end stage renal failure.
Journal of clinical pharmacology 1988;28(12):1086-8.
1988: B B Hogans; Jerry L Spivak
Tumor-promoting phorbol esters stimulate the proliferation of interleukin-3 dependent cells.
Journal of cellular physiology 1988;137(2):346-52.
1988: A P Reiner; Jerry L Spivak
Hematophagic histiocytosis. A report of 23 new patients and a review of the literature.
Medicine 1988;67(6):369-88.
1988: Marc C Hochberg; C M Arnold; B B Hogans; Jerry L Spivak
Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia.
Arthritis and rheumatism 1988;31(10):1318-21.
1988: Teresa Tiffert; Jerry L Spivak; Virgilio L Lew
Magnitude of calcium influx required to induce dehydration of normal human red cells.
Biochimica et biophysica acta 1988;943(2):157-65.
1988: Thomas S Kickler; Jerry L Spivak
Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors.
JAMA : the journal of the American Medical Association 1988;260(1):65-7.
1987: B S Bender; Thomas C Quinn; Jerry L Spivak
Homosexual men with thrombocytopenia have impaired reticuloendothelial system Fc receptor-specific clearance.
Blood 1987;70(2):392-5.
1987: Josiane E Eid; R F Ebert; M S Gesell; Jerry L Spivak
Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(2):532-6.
1986: W G Kaelin; Jerry L Spivak
Systemic lupus erythematosus and myelofibrosis.
The American journal of medicine 1986;81(5):935-8.
1986: J M McDonnell; W E Beschorner; S P Staal; Jerry L Spivak; Risa B Mann
Richter's syndrome with two different B-cell clones.
Cancer 1986;58(9):2031-7.
1986: B J Little; Jerry L Spivak; Thomas C Quinn; R B Mann
Kaposi's sarcoma with bone marrow involvement: occurrence in a patient with the acquired immunodeficiency syndrome.
The American journal of the medical sciences 1986;292(1):44-6.
1986: Jerry L Spivak
The mechanism of action of erythropoietin.
International journal of cell cloning 1986;4(3):139-66.
1986: R F Levine; Jerry L Spivak; R C Meagher; Fritz Sieber
Effect of ethanol on thrombopoiesis.
British journal of haematology 1986;62(2):345-54.
1985: Jerry L Spivak; R R Smith; J N Ihle
Interleukin 3 promotes the in vitro proliferation of murine pluripotent hematopoietic stem cells.
The Journal of clinical investigation 1985;76(4):1613-21.
1985: R R Smith; Jerry L Spivak
Marrow cell necrosis in anorexia nervosa and involuntary starvation.
British journal of haematology 1985;60(3):525-30.
1985: S H DeMent; J C Eggleston; Jerry L Spivak
Association between mediastinal germ cell tumors and hematologic malignancies. Report of two cases and review of the literature.
The American journal of surgical pathology 1985;9(1):23-30.
1984: Fritz Sieber; Jerry L Spivak; A M Sutcliffe
Selective killing of leukemic cells by merocyanine 540-mediated photosensitization.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(23):7584-7.
1984: Jerry L Spivak; B S Bender; Thomas C Quinn
Hematologic abnormalities in the acquired immune deficiency syndrome.
The American journal of medicine 1984;77(2):224-8.
1984: Georgia B Vogelsang; Jerry L Spivak
Unusual case of acute leukemia. Coexisting acute leukemia and pernicious anemia.
The American journal of medicine 1984;76(6):1144-50.
1983: Jerry L Spivak; S E Selonick; Thomas C Quinn
Acquired immune deficiency syndrome and pancytopenia.
JAMA : the journal of the American Medical Association 1983;250(22):3084-7.
1983: R C Meagher; Fritz Sieber; Jerry L Spivak
Susceptibility to merocyanine 540-mediated photosensitization: a differentiation marker on murine hematopoietic progenitor cells.
Journal of cellular physiology 1983;116(1):118-24.
1982: Jerry L Spivak
Masked megaloblastic anemia.
Archives of internal medicine 1982;142(12):2111-4.
1982: R C Meagher; Jerry L Spivak; L L Sensenbrenner; Saul J Sharkis
Thymus-conditioned medium influences in vitro colony formation by hematopoietic progenitor cells.
Stem cells 1982;2(6):321-34.
1982: R C Meagher; Fritz Sieber; Jerry L Spivak
Suppression of hematopoietic-progenitor-cell proliferation by ethanol and acetaldehyde.
The New England journal of medicine 1982;307(14):845-9.
1982: Jerry L Spivak; M Mok; J H Shaper; E D Zanjani
Solid-phase binding assay for erythropoietin antibodies.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1982;169(3):406-12.
1982: M Mok; Jerry L Spivak
Protease activity in human urine erythropoietin preparations.
Experimental hematology 1982;10(3):300-6.
1982: Fritz Sieber; R C Meagher; Jerry L Spivak
Susceptibility to merocyanine 540-mediated photosensitization as a differentiation marker in murine hematopoietic stem cells.
Progress in clinical and biological research 1982;85 Pt B():135-44.
1981: David G Roodman; Jerry L Spivak; E D Zanjani
Stimulation of erythroid colony formation in vitro by erythropoietin immobilized on agarose-bound lectins.
The Journal of laboratory and clinical medicine 1981;98(5):684-90.
1981: Fritz Sieber; Robert Stuart; Jerry L Spivak
Tumor-promoting phorbol esters stimulate myelopoiesis and suppress erythropoiesis in cultures of mouse bone marrow cells.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(7):4402-6.
1981: Fritz Sieber; R C Meagher; Jerry L Spivak
Differential sensitivity of mouse hematopoietic stem cells to merocyanine 540.
Differentiation; research in biological diversity 1981;19(1):65-7.
1980: Jerry L Spivak; J Misiti; Robert Stuart; Saul J Sharkis; L L Sensenbrenner
Suppression and potentiation of mouse hematopoietic progenitor cell proliferation by ouabain.
Blood 1980;56(2):315-7.
1980: Jerry L Spivak; S Graber
Erythropoietin and the regulation of erythropoiesis.
The Johns Hopkins medical journal 1980;146(6):311-20.
1980: Saul J Sharkis; Jerry L Spivak; A Ahmed; J Misiti; Robert Stuart; W Wiktor-Jedrzejczak; K W Sell; L L Sensenbrenner
Regulation of hematopoiesis: helper and suppressor influences of the thymus.
Blood 1980;55(3):524-7.
1979: J Misiti; Jerry L Spivak
Erythropoiesis in vitro. Role of calcium.
The Journal of clinical investigation 1979;64(6):1573-9.
1979: J Misiti; Jerry L Spivak
Separation of erythroid progenitor cells in mouse bone marrow by isokinetic-gradient sedimentation.
Blood 1979;54(1):105-16.
1979: Jerry L Spivak; L Peck
Chemical modification of nuclear proteins by erythropoietin.
American journal of hematology 1979;7(1):45-51.
1979: Jerry L Spivak; M D Hollenberg
Affinity chromatography with agarose-lectin derivatives: separation of human glycoproteins and application to erythropoietin purification.
Progress in clinical and biological research 1979;29():641-53.
1978: Jerry L Spivak; D Small; J H Shaper; M D Hollenberg
Use of immobilized lectins and other ligands for the partial purification of erythropoietin.
Blood 1978;52(6):1178-88.
1978: R L Hudson; O Castro; Jerry L Spivak; C Sampson; J W Downing
Sickle cell anemia and transposition of the great vessels.
American journal of diseases of children (1960) 1978;132(2):149-51.
1977: Jerry L Spivak; D Small; M D Hollenberg
Erythropoietin: isolation by affinity chromatography with lectin-agarose derivatives.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(10):4633-5.
1977: Jerry L Spivak
Felty's syndrome: an analytical review.
The Johns Hopkins medical journal 1977;141(3):156-62.
1977: Jerry L Spivak; D L Jackson
Pellagra: an analysis of 18 patients and a review of the literature.
The Johns Hopkins medical journal 1977;140(6):295-309.
1977: Jerry L Spivak; E Connor
A simple hypoxic chamber.
The Journal of laboratory and clinical medicine 1977;89(6):1375-8.
1976: Jerry L Spivak; C R Cooke
Polycythemia vera in an anephric man.
The American journal of the medical sciences 1976;272(3):339-44.
1976: H W Dickerman; T C Cheng; Haig Kazazian ; Jerry L Spivak
The erythropoietic mouse spleen-a model system of development.
Archives of biochemistry and biophysics 1976;177(1):1-9.
1976: B L Evatt; Jerry L Spivak; J Levin
Relationships between thrombopoiesis and erythropoiesis: with studies of the effects of preparations of thrombopoietin and erythropoietin.
Blood 1976;48(4):547-58.
1976: Jerry L Spivak
Effect of erythropoietin on chromosomal protein synthesis.
Blood 1976;47(4):581-92.
1976: A J Hadjian; Jerry L Spivak; A Kowarski; H W Dickerman; Claude J Migeon
Sterospecific tissue uptake and nuclear accumulation of testosterone in the development of the mouse erythropoietic spleen.
Blood 1976;47(4):571-80.
1976: C A Piantadosi; H W Dickerman; Jerry L Spivak
Sequential activation of splenic nuclear RNA polymerases by erythropoietin.
The Journal of clinical investigation 1976;57(1):20-6.
1973: Jerry L Spivak; S Perry
Evaluation of 51Cr as a leucocyte label.
British journal of haematology 1973;25(3):321-30.
1973: Jerry L Spivak
Letter: Kinetics of lymphocytes.
Blood 1973;42(2):325.
1973: Jerry L Spivak; D Toretti; H W Dickerman
Effect of phenylhydrazine-induced hemolytic anemia on nuclear RNA polymerase activity of the mouse spleen.
Blood 1973;42(2):257-66.
1973: W E Mitch; Jerry L Spivak; DONALD SPANGLER; W R Bell
Thrombotic thrombocytopenic purpura presenting with gynaecological manifestations.
Lancet 1973;1(7808):849-50.
1973: Jerry L Spivak
Phagocytic tumour cells.
Scandinavian journal of haematology 1973;11(3):253-6.
1972: Jerry L Spivak; DONALD SPANGLER; W R Bell
Defibrinogenation after intra-amniotic injection of hypertonic saline.
The New England journal of medicine 1972;287(7):321-3.
1972: Jerry L Spivak; J Marmor; H W Dickerman
Studies on splenic erythropoiesis in the mouse. I. Ribosomal ribonucleic acid metabolism.
The Journal of laboratory and clinical medicine 1972;79(4):526-40.
1970: D L Lilien; Jerry L Spivak; I David Goldman
Chromate transport in human leukocytes.
The Journal of clinical investigation 1970;49(8):1551-7.
1970: Jerry L Spivak; S Lindo; M Coleman
Weber-Christian disease complicated by consumption coagulopathy and microangiopathic hemolytic anemia.
The Johns Hopkins medical journal 1970;126(6):344-9.
1970: Jerry L Spivak; S Perry
Lymphocyte kinetics in chronic lymphocytic leukaemia.
British journal of haematology 1970;18(5):511-22.
1969: Jerry L Spivak; L H Brubaker; S Perry
Intravascular granulocyte kinetics in acute leukemia.
Blood 1969;34(5):582-90.
1969: Jerry L Spivak; C R Conti
Post-seizure myoglobinuria.
The Johns Hopkins medical journal 1969;124(1):18-24.
1968: L H Brubaker; Jerry L Spivak; S Perry
Nonequivalence of 3H- and 32P-labeled diisopropylfluorophosphate for the study of granulocyte kinetics.
The Journal of laboratory and clinical medicine 1968;72(5):747-53.